Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amizon (enisamium iodide) in ARVI and influenza
NCT04682444Phase 3Completed
- Sponsor
- Farmak
- Start
- Apr 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Morevirin in acute respiratory viral infection (ARVI), influenza, sponsored by Farmak. Started Apr 2009; status: completed.
02
Drugs
Morevirin
03
Conditions
acute respiratory viral infection (ARVI)influenza
Beyond the preview
Go deeper on NCT04682444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04682444.